Francesca De Luca

Heterogeneity of <i>PIK3CA</i> mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients

Marta Pestrin, Francesca Salvianti, Francesca Galardi et al. · Molecular Oncology · 2014 · 166 citations · Full text

Medicine, Genetics, Oncology +16

Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer

Francesca De Luca, Giada Rotunno, Francesca Salvianti et al. · Oncotarget · 2016 · 159 citations · Full text

Medicine, Cancer Biology, Oncology +17

Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial

Amelia McCartney, Martina Bonechi, Francesca De Luca et al. · Clinical Cancer Research · 2020 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy

Martina Bonechi, Francesca Galardi, Chiara Biagioni et al. · Oncotarget · 2018 · 54 citations · Full text

Medicine, Endocrinology, Oncology +17

Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study

Francesca Salvianti, Stefania Gelmini, Irene Mancini et al. · British Journal of Cancer · 2021 · 42 citations · Full text

Medicine, Clinical Sciences, Oncology +17